文献速递生殖医学

专家意见:通过分子遗传学受精检查挽救IVF中非典型原核人类受精卵

An expert opinion on rescuing atypically pronucleated human zygotes by molecular genetic fertilization checks in IVF.
PubMed 文献 · Hum Reprod · 2024-01-01

本文综述非典型原核受精卵的倍性评估及移植后妊娠结局,指出原核评估预测异常倍性特异性低,可导致超过50%囊胚被错误分类,建议以分子受精检查替代形态学检查作为新金标准。

要点

  • 原核评估预测异常倍性特异性低,可错误分类超过50%的非典型原核囊胚。
  • 被判为异常受精的胚胎仍可产生健康妊娠。
  • 作者建议以分子受精检查替代形态学检查作为新金标准,以增加可移植胚胎数。

核心结论

  • 原核评估虽与异常倍性结局相关,但预测发育中胚胎异常倍性状态的特异性低,而 deemed 异常受精的胚胎可产生健康妊娠。
  • 该普遍策略导致超过50%的非典型原核受精卵来源囊胚被错误分类,并系统性丢弃潜在可活胚胎。
  • 作者建议从基于形态的检查进步到分子受精检查作为新金标准,以增加可移植可活胚胎池。

研究设计与样本

  • 本文为专家意见,综述与人类胚胎倍性评估及移植后妊娠结局相关的文献。

主要发现

  • 原核评估预测异常倍性特异性低,可错误分类超过50%的非典型原核受精卵来源囊胚。
  • 被判为异常受精的胚胎仍可产生健康妊娠。

临床怎么用

  • 作者建议以分子受精检查作为新金标准,替代基于形态的检查,以增加可移植可活胚胎数。
  • 作者认为分子受精检查可能非增量且无争议地改善IVF活产率,对家庭构建及预后差、胚胎数常有限的患者尤为重要。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IVF laboratories routinely adopt morphological pronuclear assessment at the zygote stage to identify abnormally fertilized embryos deemed unsuitable for clinical use. In essence, this is a pseudo-genetic test for ploidy motivated by the notion that biparental diploidy is required for normal human life and abnormal ploidy will lead to either failed implantation, miscarriage, or significant pregnancy complications, including molar pregnancy and chorionic carcinoma. Here, we review the literature associated with ploidy assessment of human embryos derived from zygotes displaying a pronuclear configuration other than the canonical two, and the related pregnancy outcome following transfer. We highlight that pronuclear assessment, although associated with aberrant ploidy outcomes, has a low specificity in the prediction of abnormal ploidy status in the developing embryo, while embryos deemed abnormally fertilized can yield healthy pregnancies. Therefore, this universal strategy of pronuclear assessment invariably leads to incorrect classification of over 50% of blastocysts derived from atypically pronucleated zygotes, and the systematic disposal of potentially viable embryos in IVF. To overcome this limitation of current practice, we discuss the new preimplantation genetic testing technologies that enable accurate identification of the ploidy status of preimplantation embryos and suggest a progress from morphology-based checks to molecular fertilization check as the new gold standard. This alternative molecular fertilization checking represents a possible non-incremental and controversy-free improvement to live birth rates in IVF as it adds to the pool of viable embryos available for transfer. This is especially important for the purposes of 'family building' or for poor-prognosis IVF patients where embryo numbers are often limited.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Capalbo A, Cimadomo D, Coticchio G, et al. An expert opinion on rescuing atypically pronucleated human zygotes by molecular genetic fertilization checks in IVF. Hum Reprod. 2024. PMID: 39043217. doi:10.1093/humrep/deae157

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。